Skip to main content

Table 5 Adverse events (N = 13)

From: A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease

Adverse events5-day MCT treatment3-week ghrelin and MCT combination treatment
Unclearly related with the trial intervention
 Loose stools 5
 Stomach rumbling 1
 Feeling of being warm 2
 Slight elevation of CRP 2
 Slight liver dysfunction 1
Considered not to be related with the trial intervention
 Bronchial asthma1 
 Cerebral infarction1 
 Influenza infection 1
  1. Data are presented as the number of patients
  2. CRP C-reactive protein, MCT medium-chain triglyceride